Get the tools used by (smart)2 investors.

EBIT Forecast CAGR (3y) for Cytosorbents Crp

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

CTSO: Cytosorbents Crp

Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous...

1.00 USD
Price
USD
Fair Value
Upside
0.70 - 1.61
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Cytosorbents Crp's EBIT Forecast CAGR (3y):

CTSOHLTH.USBAXFNALNTHNVSTNMTC15.0%20.0%25.0%30.0%35.0%40.0%

Performance Summary
  • Ebit forecast cagr (3y) for Cytosorbents Crp is not meaningful.

How does Cytosorbents Crp's EBIT Forecast CAGR (3y) benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Cytosorbents Crp because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: EBIT Forecast CAGR (3y)

Hide this widget
ebit_proj_cagr_3y
Slug
number
Datatype
text
Format
current
Default Period
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to EBIT Forecast CAGR (3y) in the growth category include:

View Full List

Search for metric or datapoint

EBIT Forecast CAGR (3y)

Definition of EBIT Forecast CAGR (3y)

Hide this widget
Three year compound annual growth rate in forecasted ebit.

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-16.8%43.2%103.2%209.9%2060100140

The chart above depicts the distribution of ebit forecast cagr (3y) for companies operating in the Healthcare sector in the Developed economic region. Over 710 companies were considered in this analysis, and 684 had meaningful values. The average ebit forecast cagr (3y) of companies in the sector is 28.5% with a standard deviation of 37.2%.

Cytosorbents Crp's EBIT Forecast CAGR (3y) of NM ranks in the - percentile for the sector. The following table provides additional summary stats:

EBIT Forecast CAGR (3y) In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents712
Included Constituents684
Min-17.9%
Max208.0%
Median16.9%
Mean28.5%
Standard Deviation37.2%

You can find companies with similar ebit forecast cagr (3y) using this stock screener.

All rights reserved. Terms Of Use